What went wrong? The flawed concept of cerebrospinal venous insufficiency

por Valdueza, José M, Doepp, Florian, Schreiber, Stephan J, van Oosten, Bob W, Schmierer, Klaus, Paul, Friedemann, Wattjes, Mike P
Publicado 2013

Case for a new corticosteroid treatment trial in optic neuritis: review of updated evidence

por Petzold, Axel, Braithwaite, Tasanee, van Oosten, Bob W, Balk, Lisanne, Martinez-Lapiscina, Elena H, Wheeler, Russell, Wiegerinck, Nils, Waters, Christiaan, Plant, Gordon T
Publicado 2020

Natalizumab concentrations during pregnancy in three patients with multiple sclerosis

por Toorop, Alyssa A, Rispens, Theo, Strijbis, Eva MM, van Oosten, Bob W, de Jong, Brigit A, Uitdehaag, Bernard MJ, Killestein, Joep, van Kempen, Zoé LE
Publicado 2021

Fecal Microbiota Transplantation in Neurological Disorders

por Vendrik, Karuna E. W., Ooijevaar, Rogier E., de Jong, Pieter R. C., Laman, Jon D., van Oosten, Bob W., van Hilten, Jacobus J., Ducarmon, Quinten R., Keller, Josbert J., Kuijper, Eduard J., Contarino, Maria Fiorella
Publicado 2020

Disease activity following pregnancy-related discontinuation of natalizumab in MS

por Kleerekooper, Iris, van Kempen, Zoé L.E., Leurs, Cyra E., Dekker, Iris, Rispens, Theo, Lissenberg-Witte, Birgit I., van Munster, Caspar E.P., de Jong, Brigit A., van Oosten, Bob W., Uitdehaag, Bernard M.J., Wattjes, Mike P., Killestein, Joep
Publicado 2017

Personalized B-cell tailored dosing of ocrelizumab in patients with multiple sclerosis during the COVID-19 pandemic

por van Lierop, Zoë YGJ, Toorop, Alyssa A, van Ballegoij, Wouter JC, Olde Dubbelink, Tom BG, Strijbis, Eva MM, de Jong, Brigit A, van Oosten, Bob W, Moraal, Bastiaan, Teunissen, Charlotte E, Uitdehaag, Bernard MJ, Killestein, Joep, van Kempen, Zoé LE
Publicado 2021